Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (26)
  • 2024 (19)
  • 2023 (14)
  • 2022 (20)
  • 2021 (42)
  • 2020 (38)
  • 2019 (37)
  • 2018 (40)
  • 2017 (35)
  • 2016 (22)
  • 2015 (15)
  • 2014 (22)
  • 2013 (39)
  • 2012 (8)
  • 2011 (32)

Subject

  • Public and Media Affairs - also see Congressional Affairs (7)
  • Outreach/Drug Prevention (6)
  • Synthetic drugs (6)
  • Fake Pills (5)
  • Drug Trafficking (4)
  • Take Back Day (4)
  • Overdose (3)
  • Prescription Drugs (3)
  • Press Conferences (3)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Seizures (Drugs/Property) (2)
  • Congressional Affairs (1)
  • Critical Incident (1)
  • Diversion Division (1)
  • Fentanyl Awareness (1)
  • Guns/Weapons (1)
  • Major Law Enforcement Operation (1)
  • Museum and Visitors Center (1)
  • Pharmaceuticals/Pharmacists/Physicians (1)
  • Red Ribbon (1)

Drug Name

  • Fentanyl (9)
  • Methamphetamine (1)

Field Division

  • New England (306)
  • New York (146)
  • Chicago (127)
  • St. Louis (126)
  • Washington, DC (116)
  • Miami (91)
  • Seattle (80)
  • Houston (75)
  • Atlanta (71)
  • San Francisco (50)
  • El Paso (39)
  • New Jersey (34)
  • Phoenix (31)
  • San Diego (29)
  • Dallas (26)
  • Omaha (16)
  • Los Angeles (12)
  • New Orleans (9)
  • Rocky Mountain (6)
  • Louisville (4)
  • Philadelphia (4)
  • Caribe (2)
  • Detroit (1)
  • Sede (21)
Clear All Results
21 Results - Showing 1 to 10
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

Drug Enforcement Administration Announces the Seizure of Over 379 million Deadly Doses of Fentanyl in 2022

WASHINGTON – As 2022 comes to an end, the Drug Enforcement Administration is announcing the seizure of over 50.6 million fentanyl-laced, fake prescription pills and more than 10,000 pounds of fentanyl powder this calendar year. The DEA Laboratory estimates that these seizures represent more than 379 million potentially deadly doses...
PRESS RELEASE

DEA Serves Order to Show Cause on Truepill Pharmacy for its Involvement in the Unlawful Dispensing of Prescription Stimulants

WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...
PRESS RELEASE

DEA Joins with Families Across the Country to Increase Awareness about the Dangers of Fentanyl

WASHINGTON – This week the Drug Enforcement Administration (DEA) hosted regional family summits across the country in support of those who have lost loved ones to fentanyl poisoning. This is the first undertaking of its kind for the DEA field divisions and builds off the momentum of this summer’s Inaugural...
PRESS RELEASE

DEA Teams up with more than 4,300 Partners to Remove Unneeded Prescription Medications from Communities

WASHINGTON – On Oct. 29, 2022, communities across the country demonstrated their continued support for DEA’s bi-annual National Prescription Drug Take Back Day by safely disposing of more than 647,000 pounds of unneeded medications at nearly 5,000 collection sites across the country. Since its inception in 2010, DEA’s National Prescription...
PRESS RELEASE

DEA Gears Up for National Prescription Drug Take Back Day

WASHINGTON – The Drug Enforcement Administration will host its 23rd National Prescription Drug Take Back Day on Saturday, October 29, from 10 a.m. to 2 p.m. This event offers anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. For more than a decade, DEA’s National Prescription...
PRESS RELEASE

DEA Supports Healthy, Drug-free Lives with 2022 Red Ribbon Campaign

WASHINGTON – The United States Drug Enforcement Administration launched its annual Red Ribbon Campaign – the nation’s largest drug prevention effort – on October 23 to unite communities across the country in the shared goal of preventing drug use and addiction. This year’s theme, “Celebrate Life. Live Drug Free,” reminds...
PRESS RELEASE

DEA Announces Significant Fentanyl Seizure in New York

WASHINGTON – Yesterday, DEA and the Office of the Special Narcotics Prosecutor for the City of New York announced a significant seizure of fentanyl. Two individuals in New York have been charged following the seizure of approximately 300,000 rainbow fentanyl pills, 20 pounds of fentanyl in white and blue powder...
PRESS RELEASE

DEA Announces Results of Enforcement Surge to Reduce the Fentanyl Supply Across the United States

WASHINGTON – The U.S. Drug Enforcement Administration today announced the results of an enforcement operation that spanned from May to September and resulted in significant fentanyl seizures across the United States. As part of the One Pill Can Kill initiative, the DEA and its law enforcement partners seized more than...
PRESS RELEASE

DEA Dedicates September 11th Memorial

WASHINGTON - On Friday, September 9, 2022, the Drug Enforcement Administration dedicated a memorial at DEA Headquarters in Arlington, Virginia to DEA New York Drug Enforcement Task Force Officers who have lost their lives from illness or disease caused by their work at Ground Zero after the terrorist attacks of...

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster